API Gallery
The Phenylephrine Hydrochloride market is projected to grow at a CAGR of 1.1% from 2025 to 2035, driven by its widespread use as a nasal decongestant, vasopressor agent, and ophthalmic mydriatic across hospital, retail, and emergency care settings.
The Phenytoin market is projected to grow at a CAGR of 4.3% from 2025 to 2035, driven by the continued global burden of epilepsy, increasing demand for cost-effective antiepileptic drugs, and widespread use in seizure prophylaxis, particularly in low- and middle-income countries.
The Phenytoin Sodium market is projected to grow at a CAGR of 2.5% from 2025 to 2035, driven by the continued demand for effective seizure management in epilepsy patients, the increasing global prevalence of neurological disorders, and the expansion of generic formulations offering affordable options for treatment.
The Phloroglucinol market is projected to grow at a CAGR of 3.5% from 2025 to 2035, driven by its increasing use in gastrointestinal disorders, expanding pharmaceutical applications, and its role in the management of spastic conditions.
The Pholcodine market is projected to grow at a CAGR of 3.1% from 2025 to 2035, driven by increasing cases of upper respiratory tract infections, growing demand for non-codeine-based antitussives, and expanding over-the-counter availability in certain regions.
The Phosphoric Acid market is projected to grow at a CAGR of 3.2% from 2025 to 2035, driven by its wide application across various industries, including fertilizer production, food and beverage, water treatment, and pharmaceuticals.
The Phthalylsulfathiazole market is projected to grow at a CAGR of 3.8% from 2025 to 2035, driven by the continued need for effective antimicrobial agents, particularly in gastrointestinal infections caused by bacteria.
The Dequalinium Chloride market is projected to grow at a CAGR of 6.7% during the forecast period from 2025 to 2035, driven by increasing demand in the pharmaceutical and personal care sectors.
The Deruxtecan market is witnessing significant growth, projected to expand at a CAGR of 13.5% from 2025 to 2035. This growth is being driven by the rising prevalence of HER2-positive breast, gastric, and non-small cell lung cancers (NSCLC), as well as increasing awareness among oncologists about the efficacy and safety profile of ADCs in managing complex cancer cases.
The Desflurane market is projected to grow at a CAGR of 4.3% during the forecast period 2025 to 2035, influenced by its continued use as a volatile anesthetic agent in general surgeries, especially in outpatient and fast-track surgical procedures.
The Desidustat market is expected to witness a CAGR of 9.1% during the forecast period of 2025 to 2035, driven by the increasing prevalence of anemia associated with chronic kidney disease (CKD) and a growing shift toward oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitors.
The Desipramine Hydrochloride market is expected to grow at a CAGR of 4.8% from 2025 to 2035, driven by rising incidences of treatment-resistant depression and an increasing demand for cost-effective psychiatric medications.
The Desloratadine market is projected to grow at a CAGR of 5.8% during the forecast period from 2025 to 2035, driven by increasing cases of allergic rhinitis, chronic urticaria, and other seasonal allergic disorders globally.
The Desmopressin Acetate market is projected to grow at a CAGR of 6.4% from 2025 to 2035, driven by the increasing global prevalence of diabetes insipidus, nocturnal enuresis, and bleeding disorders such as hemophilia A and von Willebrand disease.
The Desmopressin market is projected to grow at a CAGR of 6.1% during the forecast period from 2025 to 2035, driven by rising cases of diabetes insipidus, nocturnal enuresis, hemophilia A, and von Willebrand disease.
Search from 10,000 + API reports
How can we help you?
Reach out to discuss how our team can help your business achieve real results.
